Genflow Biosciences Plc (GENF) Posts H1 2026 Report, Cash £632.6K After £1.15M Raise

Genflow Biosciences Plc reported unaudited H1 2026 results: cash £632,553 at 30 Jun 2026 after £1,148,875 net equity raise; admin expenses £454,311. SLAB canine trial completed; full results to be presented Oct 2, 2026.Material DetailsContext by AI AnalystEarly-stage biotech updating on cash runway…